| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Zoon Kathryn C is a Director at Emergent BioSolutions Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $682K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | EBS Emergent Biosolutions Inc. | Director | Sell | 7,086 | $8.87 | $62,852.82 | -9.0% | +16.7% | - | |
| Mar 12, 2025 | EBS Emergent Biosolutions Inc. | Director | Sell | 10,000 | $5.73 | $57,300.00 | -18.4% | +9.8% | +32.2% | |
| Jun 4, 2024 | EBS Emergent Biosolutions Inc. | Director | Sell | 10,000 | $6.11 | $61,100.00 | -15.5% | +32.9% | +13.8% | |
| May 29, 2024 | EBS Emergent Biosolutions Inc. | Director | Sell | 1,830 | $4.61 | $8,436.30 | -2.8% | +100.0% | +39.2% | |
| May 21, 2024 | EBS Emergent Biosolutions Inc. | Director | Sell | 1,089 | $5.78 | $6,294.42 | -2.2% | +133.6% | +24.1% | |
| Jun 2, 2023 | EBS Emergent Biosolutions Inc. | Director | Sell | 3,530 | $8.36 | $29,526.50 | -3.4% | -43.1% | -30.8% | |
| Jun 9, 2022 | EBS Emergent Biosolutions Inc. | Director | Sell | 1,173 | $31.52 | $36,972.96 | -5.6% | -27.8% | -73.8% | |
| May 24, 2022 | EBS Emergent Biosolutions Inc. | Director | Sell | 1,996 | $35.53 | $70,917.88 | -13.9% | -18.1% | -74.7% | |
| May 25, 2021 | EBS Emergent Biosolutions Inc. | Director | Sell | 3,139 | $56.48 | $177,290.72 | -17.9% | +12.5% | -40.4% | |
| Aug 10, 2020 | EBS Emergent Biosolutions Inc. | Director | Sell | 1,000 | $130.27 | $130,270.00 | -7.4% | - | - |